Levobupivacaína Kabi

Levobupivacaine, the active ingredient in Levobupivacaína Kabi, is a local anesthetic (amide type) presented as a sterile solution for epidural, infiltration, intrathecal, and peripheral nerve use. It provides regional anesthesia for surgical procedures, postoperative pain control, and labor analgesia. GNH USA supplies Levobupivacaína Kabi as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Levobupivacaine is an amide-type local anesthetic used in various regional anesthesia techniques.

Surgical anesthesia: provides intra‑operative analgesia and muscle relaxation during operative procedures. Post‑operative analgesia: extends pain relief after surgery to reduce opioid requirements. Labor analgesia: offers effective pain control during childbirth while preserving maternal consciousness.

Adverse reactions may occur following administration of levobupivacaine.

Common Side Effects: - Hypotension: decreased blood pressure due to vasodilation. - Bradycardia: slowed heart rate, especially with high spinal blocks. - Nausea: mild gastrointestinal upset. - Vasodilation: transient flushing or warmth. - Dizziness: feeling light‑headed after injection. - Metallic taste: occasional oral sensation.

Serious or Rare Side Effects: - Cardiac arrest: severe cardiotoxicity at high plasma concentrations. - Seizures: central nervous system excitation from excessive dosing. - Methemoglobinemia: reduced oxygen‑carrying capacity of blood. - Allergic reactions: urticaria, bronchospasm, or anaphylaxis. - Persistent neurologic deficit: prolonged numbness or motor weakness. - Respiratory depression: especially when combined with other depressants.

When using levobupivacaine, clinicians should observe several safety measures.

Assess cardiovascular status: monitor blood pressure and heart rate before and during administration. Avoid intravascular injection: aspirate before injection to prevent systemic toxicity. Use incremental dosing: limit total dose per procedure and observe patient response. Consider patient comorbidities: adjust dosing for hepatic impairment or advanced age. Store at ambient temperature: keep in original container, protect from light and moisture.

Levobupivacaine may interact with other medications, requiring careful management.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): increase risk of cardiotoxicity. - Beta‑blockers: may exacerbate bradycardia. - General anesthetics (e.g., halothane): additive central nervous system depression.

Moderate Interactions (Monitor Closely): - Opioids: enhanced analgesic effect, monitor respiratory status. - Vasopressors: may mask hypotension caused by the anesthetic. - Other local anesthetics: cumulative toxicity risk when combined.